A detailed history of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Empirical Financial Services, LLC D.B.A. Empirical Wealth Management holds 7,819 shares of LLY stock, worth $7.15 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
7,819
Previous 4,564 71.32%
Holding current value
$7.15 Million
Previous $2.66 Million 128.65%
% of portfolio
0.18%
Previous 0.09%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$592.2 - $792.28 $1.93 Million - $2.58 Million
3,255 Added 71.32%
7,819 $6.08 Million
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $318,265 - $375,192
-606 Reduced 11.72%
4,564 $2.66 Million
Q3 2023

Nov 02, 2023

BUY
$434.7 - $599.3 $518,597 - $714,964
1,193 Added 30.0%
5,170 $2.78 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $124,863 - $166,956
-356 Reduced 8.22%
3,977 $1.87 Million
Q1 2023

May 09, 2023

SELL
$310.63 - $364.82 $511,607 - $600,858
-1,647 Reduced 27.54%
4,333 $1.49 Million
Q4 2022

Feb 07, 2023

BUY
$321.55 - $374.67 $405,153 - $472,084
1,260 Added 26.69%
5,980 $2.19 Million
Q3 2022

Nov 02, 2022

SELL
$296.48 - $337.87 $175,516 - $200,019
-592 Reduced 11.14%
4,720 $1.53 Million
Q2 2022

Aug 02, 2022

BUY
$278.73 - $327.27 $274,827 - $322,688
986 Added 22.79%
5,312 $1.72 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $35,672 - $44,332
-152 Reduced 3.39%
4,326 $1.24 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $252,056 - $312,803
1,121 Added 33.39%
4,478 $1.24 Million
Q3 2021

Nov 02, 2021

SELL
$221.6 - $272.71 $379,822 - $467,424
-1,714 Reduced 33.8%
3,357 $776,000
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $42,068 - $54,414
233 Added 4.82%
5,071 $1.16 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $14,788 - $19,144
90 Added 1.9%
4,838 $904,000
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $48,139 - $63,700
-369 Reduced 7.21%
4,748 $802,000
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $18,277 - $21,141
-125 Reduced 2.38%
5,117 $757,000
Q2 2020

Aug 12, 2020

BUY
$136.42 - $164.18 $56,205 - $67,642
412 Added 8.53%
5,242 $861,000
Q1 2020

May 11, 2020

SELL
$119.05 - $147.35 $11,905 - $14,735
-100 Reduced 2.03%
4,830 $670,000
Q4 2019

Feb 13, 2020

BUY
$106.92 - $132.43 $99,970 - $123,822
935 Added 23.4%
4,930 $648,000
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $36,628 - $39,842
343 Added 9.39%
3,995 $447,000
Q2 2019

Aug 12, 2019

SELL
$110.79 - $129.32 $111,233 - $129,837
-1,004 Reduced 21.56%
3,652 $405,000
Q1 2019

May 13, 2019

BUY
$111.31 - $131.02 $44,524 - $52,408
400 Added 9.4%
4,656 $604,000
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $198,033 - $221,856
1,870 Added 78.37%
4,256 $493,000
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $3,691 - $4,614
43 Added 1.84%
2,386 $256,000
Q2 2018

Aug 13, 2018

BUY
$75.7 - $86.88 $177,365 - $203,559
2,343 New
2,343 $200,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Portfolio

Follow Empirical Financial Services, LLC D.B.A. Empirical Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Financial Services, LLC D.B.A. Empirical Wealth Management with notifications on news.